$1.03 Billion is the total value of TANG CAPITAL MANAGEMENT LLC's 21 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 32.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ODT | ODONATE THERAPEUTICS INC | $595,947,000 | +53.4% | 14,075,269 | 0.0% | 57.94% | +6.2% | |
| BHVN | New | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $71,682,000 | – | 980,461 | +100.0% | 6.97% | – |
| RCKT | ROCKET PHARMACEUTICALS INC | $62,068,000 | +50.0% | 2,965,485 | 0.0% | 6.03% | +3.9% | |
| ANAB | Buy | ANAPTYSBIO INC | $56,491,000 | +74.5% | 2,528,678 | +10.4% | 5.49% | +20.8% |
| HRTX | HERON THERAPEUTICS INC | $42,613,000 | +25.3% | 2,896,904 | 0.0% | 4.14% | -13.3% | |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $37,043,000 | +9.2% | 8,695,474 | +7.6% | 3.60% | -24.4% |
| BIO | BIO RAD LABS INCcl a | $36,119,000 | +28.8% | 80,000 | 0.0% | 3.51% | -10.8% | |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $24,200,000 | +22.5% | 200,000 | -4.0% | 2.35% | -15.2% |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $22,375,000 | -49.5% | 500,000 | -61.5% | 2.18% | -65.1% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $14,241,000 | +110.9% | 1,365,376 | +70.7% | 1.38% | +46.0% |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $14,146,000 | +9.2% | 1,578,795 | -22.3% | 1.38% | -24.4% |
| AVRO | Sell | AVROBIO INC | $13,960,000 | -10.3% | 800,000 | -20.0% | 1.36% | -37.9% |
| EGRX | EAGLE PHARMACEUTICALS INC | $12,264,000 | +4.3% | 255,616 | 0.0% | 1.19% | -27.8% | |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $9,823,000 | +73.0% | 550,000 | +57.1% | 0.96% | +19.8% |
| LSACU | LIFESCI ACQUISITION CORPunit 03/31/2025 | $5,500,000 | +10.0% | 500,000 | 0.0% | 0.54% | -23.8% | |
| PRTA | Sell | PROTHENA CORP PLC | $2,864,000 | -36.8% | 273,823 | -35.4% | 0.28% | -56.4% |
| CTMX | CYTOMX THERAPEUTICS INC | $2,499,000 | +8.6% | 300,000 | 0.0% | 0.24% | -24.8% | |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $2,190,000 | -29.5% | 191,426 | -36.1% | 0.21% | -51.1% |
| RDUS | Sell | RADIUS HEALTH INC | $1,622,000 | -58.4% | 119,005 | -60.3% | 0.16% | -71.2% |
| NCNA | NUCANA PLCsponsored adr | $541,000 | -7.2% | 100,000 | 0.0% | 0.05% | -35.4% | |
| New | TENAX THERAPEUTICS INC | $416,000 | – | 460,000 | +100.0% | 0.04% | – | |
| UPS | Exit | UNITED PARCEL SERVICE INCcl b | $0 | – | -1,000 | -100.0% | -0.01% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -431,273 | -100.0% | -0.09% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -41,444 | -100.0% | -0.09% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -13,483 | -100.0% | -0.10% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -170,000 | -100.0% | -0.26% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -3,295,000 | -100.0% | -1.92% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
| 4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.